eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | rheumatoid arthritis |
| Symptom | C0206062|interstitial lung disease |
| Sentences | 23 |
| PubMedID- 25922727 | This study investigates the association between the relative proportions of cd19(+)foxp3(+) and cd19(+)tgfbeta(+) bregs, and clinical indicators of disease severity in rheumatoid arthritis (ra) patients with or without interstitial lung disease (ild). |
| PubMedID- 25026811 | Subclinical interstitial lung disease associated with rheumatoid arthritis. |
| PubMedID- 24681838 | Comment on: a case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis. |
| PubMedID- 24570384 | interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. |
| PubMedID- 25125479 | Potential risk of tnf inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis. |
| PubMedID- 26401101 | Management of rheumatoid arthritis patients with interstitial lung disease: safety of biological antirheumatic drugs and assessment of pulmonary fibrosis. |
| PubMedID- 22341526 | Objective: to describe the evolution of lung function in a cohort of rheumatoid arthritis (ra) patients with interstitial lung disease (ild) treated according to the medical judgment of attending physicians. |
| PubMedID- 26075419 | A guide to improving detection of interstitial lung disease in patients with rheumatoid arthritis. |
| PubMedID- 26508946 | However, these agents are widely prescribed for patients with ankylosing spondylitis, and case reports describe beneficial effects in patients with interstitial lung disease associated with rheumatoid arthritis. |
| PubMedID- 24378059 | Objective: to investigate the effect of selective phosphodiesterase (pde) 4 inhibitors on nuclear factor kappa b (nf-kappab), tumor necrosis factor-alpha (tnfalpha) and interleukin-8 (il-8) secreted by peripheral blood mononuclear cells (pbmcs) in patients diagnosed as rheumatoid arthritis with interstitial lung disease (ra-ild). |
| PubMedID- 25665185 | Sonographic assessment of interstitial lung disease in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus. |
| PubMedID- 23819345 | Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis. |
| PubMedID- 25744479 | Backgrounds: interstitial lung disease (ild) is associated with rheumatoid arthritis (ra) itself and is also induced by biological and non-biological disease-modifying antirheumatic drugs. |
| PubMedID- 21325762 | Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of pneumocystis pneumonia in japan revealed by a multicenter study. |
| PubMedID- 20480164 | A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab. |
| PubMedID- 25417684 | Abatacept therapy in rheumatoid arthritis with interstitial lung disease. |
| PubMedID- 24681841 | Comment on: a case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: reply. |
| PubMedID- 25746669 | A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in chinese patients. |
| PubMedID- 24743261 | Anti-cyclic citrullinated peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis. |
| PubMedID- 24521636 | Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study. |
| PubMedID- 26090479 | Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis. |
| PubMedID- 24626274 | Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis. |
| PubMedID- 23661426 | A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis. |
Page: 1